Cargando…
Marker of schizophrenia with enduring negative symptoms
INTRODUCTION: The relevance of this study is determined by the need to search for biological markers of schizophrenia. The detection and validation of such molecules can become the basis for the creation of additional paraclinical diagnostic methods or contribute to the creation of targets for indiv...
Autores principales: | Dmitrieva, E., Smirnova, L., Semke, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567590/ http://dx.doi.org/10.1192/j.eurpsy.2022.2001 |
Ejemplares similares
-
Superoxide dismutase activity of serum IgG in acute illness and remission period of schizophrenia
por: Mednova, I., et al.
Publicado: (2022) -
DNA-hydrolyzing catalytic IgGs from schizophrenia patients do not affect cell viability of the SH-SY5Y human neuroblastoma cell line
por: Epimakhova, E., et al.
Publicado: (2022) -
Proteomic profile of serum from patients with schizophrenia spectrum disorders
por: Dmitrieva, Elena, et al.
Publicado: (2022) -
Predictive biomarkers for negative symptoms in schizophrenia
por: Cakici, N., et al.
Publicado: (2021) -
The structure stability of negative symptoms: longitudinal network analysis of the Brief Negative Symptom Scale in subjects with schizophrenia
por: Caporusso, E., et al.
Publicado: (2023)